- Who can participate: Individuals aged 18 to 65 with a diagnosis of chronic pain lasting more than six months are eligible to participate. Participants should not have any other significant health conditions that could interfere with the study.
- Study details: Participants will be randomly assigned to receive either the investigational treatment or a placebo. The study involves regular assessments of pain levels and overall health to monitor the treatment's impact.